Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative Neoplasms
Pinkal Desai(NewYork–Presbyterian Hospital), Gail J. Roboz(Cornell University), Tania J. Curcio(Cornell University), Niamh Savage(Cornell University), Spencer Krichevsky(Cornell University), Ellen K. Ritchie(Cornell University), Sang‐Min Lee(Seoul National University), Michael Samuel(NewYork–Presbyterian Hospital)
Cited by 0
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k